(PharmaNewsWire.Com, April 02, 2024 ) As per Maximize Market research, the Haemodialysis and Peritoneal Dialysis Market was USD 104.08 Billion in 2023 and is expected to grow at a CAGR of 9.3 percent over the forecast period to reach USD 193.96 Billion by 2030.
Haemodialysis and Peritoneal Dialysis Market Report Scope and Research Methodology
The research approach comprises both primary and secondary data research, accompanied by market surveys and expert interviews, to draw a picture beyond these two kidney dialysis techniques. The scope of the report for the Haemodialysis and Peritoneal Dialysis is carried out to conduct a detailed study of demand factors, market dynamics, and certain geographical regions.
Haemodialysis and Peritoneal Dialysis Market Dynamics
The enlarging pools of chronic kidney diseases (CKD), such as diabetes and hypertension form a huge portion of the community requiring dialysis treatment. However, the issue of ESRD is only going to be more pervasive in the current demographic, and lifestyles and those things get trigger the escalation of ESRD globally.
Haemodialysis and Peritoneal Dialysis Market Regional Analysis
The North American region dominated the market and continues to grow as the prevalence of end-stage renal disease (ESRD) rises, as an ageing population is increasing and an increase in patients with diabetes and hypertension. Innovations related to technology, such as wearable dialysis equipment and biocompatible solutions are helping to improve patient outcomes while driving market growth.
Haemodialysis and Peritoneal Dialysis’s Key Players include
Braun SE.
Fresenius Medical Care AG.
Asahi Kasei Medical Co., Ltd.
Maximize Market Research is leading Healthcare research firm, has also published the following reports:
DialysisMarket- The market is expected to reach USD 189.67 Bn. by 2029 at a CAGR of 7.7 percent.
PeritonealDialysis Market- The market is expected to reach USD 53.66 Bn. by 2030 at a CAGR of 5.96 percent.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities and technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics and communications, Internet of Things, Food and Beverages, Aerospace and defense, and other manufacturing sectors.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
